Clearmind gets clearance to advance AUD drug trial to patient cohorts

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. IONQ
3. USO
4. IONS
5. AAPL
6. ACN
7. AZN
8. ROIV
9. HOOD
10. QCOM

Go back to Clearmind gets clearance to advance AUD drug trial to patient cohorts
(NASDAQ: CMND) Delayed: 1.02 -0.14 (12.07%)
Previous Close $1.16    52 Week High $ 
Open $1.15    52 Week Low $ 
Day High $1.15    P/E N/A 
Day Low $0.92    EPS $ 
Volume 2,285,323